Mental Disorders

286 trials 120 recruiting

Filter these 286 trials by phase, country and sponsor.

Open in Search →

Pharmacological treatment of compulsive sexual behaviour disorder Recruiting

2024-514490-22-01 Compulsive Sexual Behaviour Disorder 5 2025-06-12
A New Intervention for Implementation of Pharmacogenetics in Psychiatry Recruiting

2023-509680-25-00 Mood disorder (major depressive disorder and bipolar di 6 2025-06-03
PsyPal; Psilocybin Therapy for Psychological Distress in Palliative Patients Recruiting

2023-510488-36-01 Chronic obstructive pulmonary disease (COPD), amyotroph 4 2025-06-01
Randomized, placebo-controlled clinical trial to investigate the safety and efficacy of two dexamfetamine sulfate formulations in adults wit… Recruiting

2024-515395-12-00 Adults with ADHD and moderate to severe depression 4 2025-05-22
High-Intensity Inpatient MDMA-Assisted Psychotherapy for Treatment-Refractory Posttraumatic Stress Disorder: An Open-Label Pilot Study Recruiting

2023-508229-28-00 posttraumatic stress disorder 4 2025-05-16
Sema.Mood Recruiting

2024-511734-13-04 Unipolar depression Overweight and obesity 11 2025-05-15
Traitement des Idées Suicidaires aux urgences par adjonction de Protoxyde d’Azote (PROTORISC pilote) Recruiting

2023-506329-12-00 Treatment of suicidal ideation 4 2025-05-14
Can treatment with tirzepatide reduce alcohol intake in individuals diagnosed with schizophrenia and alcohol use disorder (DUALPSYCHIATRY) Recruiting

2024-518608-28-00 Schizophrenia and Alcohol Use Disorder 4 2025-05-01
A Phase 3, Parallel Group Study to Evaluate KarXT as a Treatment for Psychosis Associated with Alzheimer’s Disease Recruiting

2024-516363-92-00 Psychosis Associated with Alzheimer’s Disease 5 2025-04-08
The dual orexin receptor antagonist daridorexant as an adjunct to improve buprenorphine maintenance therapy of opioid use disorder Recruiting

2024-517482-16-00 Opioid Use Disorder [OUD] 4 2025-04-04
Esketamine nasal spray (Spravato) for the treatment of therapy-resistant bipolar depression. An open-label pilot trial. Recruiting

2023-508125-27-00 Bipolar disorder- depressive episode 4 2025-04-01
A study to measure how well seltorexant works in adult depressed patients and how safe it is both for short- and long-term use when taken wi… Recruiting

2023-509070-36-00 Major Depressive Disorder with Insomnia Symptoms 5 2025-03-18
A study to assess the efficacy and safety of lumateperone in patients with major depressive disorder Recruiting

2023-503836-41-00 Major Depressive Disorder 5 2025-03-10
Ketamine for depression and alcohol use disorder Recruiting

2023-506052-24-00 Depression 9 2025-01-20
Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis (SchizOMICS) Recruiting

2024-516768-28-00 Schizophrenia 6 2024-12-16
Early efficacy of ketamine compared to placebo, in add-on therapy of venlafaxine for inpatients with severe unipolar major depressive episod… Recruiting

2023-506597-12-00 Major depressive disorder with current severe major dep 5 2024-11-20
REVERSE: a randomized controlled trial (RCT) to ameliorate treatment-resistant Post Traumatic Stress Disorder (PTSD) with Glucocorticoid Rec… Recruiting

2024-511042-39-00 Post-traumatic stress disorder (PTSD) 4 2024-11-13
RA-P-OCD-01 Recruiting

2024-518391-31-00 Psychosis and or Obsessive Compulsive Disorder, with an 4 2024-11-05
Randomized, double-blind, placebo-controlled trial evaluating efficacy and safety of dimethyl fumarate in brain atrophy reduction, synaptic … Recruiting

2024-517214-16-00 Alzheimer’s disease 4 2024-10-28
Cortisol in personalized treatment for posttraumatic stress disorder (PTSD) Recruiting

2024-516427-13-00 Posttraumatic Stress Disorder (PTSD) 6 2024-10-28
Dextroamphetamine Substitution for Amphetamines Dependence: A Randomized Controlled Trial Recruiting

2023-508291-11-00 Comorbid dependencies to amphetamines and opioids 4 2024-09-18
Enhancing social skills in schizophrenia spectrum disorders – two-arm, double-blind, randomized clinical trial investigating oxytocin vs. p… Recruiting

2023-509433-40-00 schizophrenia or other primary psychotic disorders (SSD 4 2024-08-29
A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for major depressive disorder c… Recruiting

2023-506617-21-00 Major depressive disorder 5 2024-08-29
Patient- and care-related benefits of amyloid PET imaging (ENABLE) Recruiting

2023-503705-10-00 Dementia in Pick disease 6 2024-08-19